Moritz C. Wyler von Ballmoos (@drmoritzwvb) 's Twitter Profile
Moritz C. Wyler von Ballmoos

@drmoritzwvb

Professor and System Chairman of Cardiovascular & Thoracic Surgery @texashealth. Never stop exploring.

ID: 1038494267780616192

linkhttp://bit.ly/heart_surgery calendar_today08-09-2018 18:28:22

1,1K Tweet

2,2K Followers

806 Following

Karen M Kim, MD (@karenmkimmd1) 's Twitter Profile Photo

Calling all perfusionists! Apply for a The Society of Thoracic Surgeons The Thoracic Surgery Foundation (TSF) Sarns Terumo Perfusion Fellowship Award to learn new techniques, make new connections within the cardiothoracic surgery community, and advance heart and lung care for all! Deadline Sept 15

Moritz C. Wyler von Ballmoos (@drmoritzwvb) 's Twitter Profile Photo

The important symbiosis between less-invasive surgical techniques & a comprehensive, systematic approach to perioperative care: It is the philosophy & approach we use at TexasHealthResources to provide our patients with an optimized recovery and best outcomes. doi.org/10.1177/155698…

Dmytro Babliak, MD (@babliakd) 's Twitter Profile Photo

Looks like Friday, October 11th, will be especially interesting for the Mitral Valve! I’m starting to create my personal schedule for the #EACTS2024 38th Annual Meeting.

Looks like Friday, October 11th, will be especially interesting for the Mitral Valve! I’m starting to create my personal schedule for the #EACTS2024 38th Annual Meeting.
The Annals of Thoracic Surgery (@annalsthorsurg) 's Twitter Profile Photo

#EditorsChoice In this analysis, Vinod Thourani, Vinay Badhwar & coauthors aim to provide contemporary, clinically relevant information to patients and providers and to develop the initial STS risk model for isolated tricuspid valve operationsšŸ‘‡ doi.org/10.1016/j.atho…

#EditorsChoice In this analysis, <a href="/VinodThourani/">Vinod Thourani</a>, <a href="/BadhwarVinay/">Vinay Badhwar</a> &amp; coauthors aim to provide contemporary, clinically relevant information to patients and providers and to develop the initial STS risk model for isolated tricuspid valve operationsšŸ‘‡
doi.org/10.1016/j.atho…
Moritz C. Wyler von Ballmoos (@drmoritzwvb) 's Twitter Profile Photo

Not the trend that most expected… ā€œIn this cohort study, analysis of 210 495 patients in a large US registry cohort showed an increase in risk-adjusted odds for 30-day mortality [with #TAVR] after adjusting for patient and procedural characteristics.ā€ jamanetwork.com/journals/jamac…

TexasHealthResources (@texashealth) 's Twitter Profile Photo

Congrats! #TexasHealth Fort Worth recently earned Transcatheter Valve Certification, the first facility in North Texas to earn the national certification from the American College of Cardiology. bit.ly/4e4wsu2

Congrats! #TexasHealth Fort Worth recently earned Transcatheter Valve Certification, the first facility in North Texas to earn the national certification from the American College of Cardiology.
bit.ly/4e4wsu2
Moritz C. Wyler von Ballmoos (@drmoritzwvb) 's Twitter Profile Photo

Outstanding team work at Texas Health Fort Worth Harris Methodist Hospital making compassionate, high-complexity cardiovascular care possible 24/7 to take care of some of the sickest patients in DFW & beyond. ⁦TexasHealthResources⁩ #1choice4HeartandVascular linkedin.com/posts/wylervon…

ISMICSofficial (@ismics) 's Twitter Profile Photo

@ISMICS1997 has extended their deadline to January 3! Submit your abstract and be considered for #ISMICS2025 in Istanbul, Turkey!!

@ISMICS1997 has extended their deadline to January 3! Submit your abstract and be considered for #ISMICS2025 in Istanbul, Turkey!!
JACC Journals (@jaccjournals) 's Twitter Profile Photo

#STS2025 #JACC LBCT: In pts 60 years of age or younger, mechanical #AVR was associated with an independent risk-adjusted survival benefit compared to bioprosthetic AVR. jacc.org/doi/10.1016/j.… J. Hunter Mehaffey Moritz C. Wyler von Ballmoos The Society of Thoracic Surgeons Vinay Badhwar

#STS2025 #JACC LBCT: In pts 60 years of age or younger, mechanical #AVR was associated with an independent risk-adjusted survival benefit compared to bioprosthetic AVR. jacc.org/doi/10.1016/j.…

<a href="/hunter_mehaffey/">J. Hunter Mehaffey</a> <a href="/DrMoritzWvB/">Moritz C. Wyler von Ballmoos</a> <a href="/STS_CTsurgery/">The Society of Thoracic Surgeons</a> <a href="/BadhwarVinay/">Vinay Badhwar</a>
Moritz C. Wyler von Ballmoos (@drmoritzwvb) 's Twitter Profile Photo

Still time to register for the Re-Evolution Summit: the ultimate hands-on training course in minimally invasive cardiac surgery! This year again with an incredible faculty lineup - covering all aspects & variations of MICS, link: learn.houstonmethodist.org/cardiovascular…

Still time to register for the Re-Evolution Summit: the ultimate hands-on training course in minimally invasive cardiac surgery! This year again with an incredible faculty lineup - covering all aspects &amp; variations of MICS, link:
learn.houstonmethodist.org/cardiovascular…
JAMA Cardiology (@jamacardio) 's Twitter Profile Photo

From JAMA: In patients needing coagulation factor replacement after cardiac surgery, prothrombin complex concentrate showed superior hemostatic effectiveness & fewer serious adverse events & acute kidney injuries compared to frozen plasma. #ACC25 ja.ma/3QPCkhM

From <a href="/JAMA_current/">JAMA</a>: In patients needing coagulation factor replacement after cardiac surgery, prothrombin complex concentrate showed superior hemostatic effectiveness &amp; fewer serious adverse events &amp; acute kidney injuries compared to frozen plasma. #ACC25

ja.ma/3QPCkhM
Moritz C. Wyler von Ballmoos (@drmoritzwvb) 's Twitter Profile Photo

It was great to be faculty at ACC25 - discussing the management of MR regurgitation in patients being considered for TAVR, and all other things structural heart disease. Catching up with friends and colleagues all rallying together to help our patients with cardiovascular disease

CardioVisual: Powered by MedicalVisual (@cardiovisualapp) 's Twitter Profile Photo

Sneak peek into what's coming šŸ‘€ CardioVisual went to #ACC25 and spoke to leading experts about topics ranging from women's heart disease, advances in valvular disease, late breaking trials, and much more!